HYBRID EVENT: You can participate in person at London, UK or Virtually from your home or work.

6th Edition of International Conference on Tissue Engineering and Regenerative Medicine

September 28-30 | London, UK

September 28 -30, 2026 | London, UK

Recellularization

Recellularization

Recellularization is a transformative process in tissue engineering that involves repopulating a decellularized tissue scaffold with living cells to restore its structure and function. Decellularization is the initial step, where cells are removed from a tissue or organ, leaving behind a three-dimensional extracellular matrix. This acellular matrix retains the tissue's architecture, mechanical properties, and signaling cues. Recellularization follows, where the acellular scaffold is infused with the desired cell types, such as stem cells or differentiated cells, allowing them to adhere, proliferate, and differentiate within the matrix. The goal is to create functional, bioengineered tissues that closely mimic native structures. Recellularization has been applied to various organs, including the heart, lungs, liver, and kidneys, offering potential solutions for organ transplantation shortages. This technique is not only a means to generate replacement organs but also serves as a valuable tool for drug testing, disease modeling, and understanding cell-matrix interactions. Challenges in achieving optimal recellularization include maintaining cell viability, promoting proper tissue integration, and ensuring appropriate functionality. Ongoing research continues to refine recellularization techniques, addressing these challenges and unlocking the full potential of this innovative approach in regenerative medicine.

Committee Members
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Nagy Habib

Nagy Habib

Imperial College London, United Kingdom
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Lucie Bacakova

Lucie Bacakova

Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Speaker at Tissue Engineering and Regenerative Medicine 2026 - Marco Polettini

Marco Polettini

DVM, Italy

Submit your abstract Today

Youtube
Watsapp